Home › Huntington's Disease › Maryland › Baltimore
Huntington's Disease clinical trials in Baltimore, MD
4 studies for Huntington's Disease are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pridopidine Phase 3 Study in Huntington's Disease
RecruitingPhase 3
- Johns Hopkins University, Baltimore
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RecruitingPhase 3
- Johns Hopkins University, Baltimore
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
RecruitingObservational studyHealthy volunteers welcome
- John Hopkins University, Baltimore
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
RecruitingObservational studyHealthy volunteers welcome
- Johns Hopkins University, Baltimore
About Huntington's Disease
Huntington's disease (HD) is an inherited disease that causes nerve cells in the brain to waste away. It causes disability that gets worse over time.
More about Huntington's Disease on MedlinePlus
Huntington's Disease trials in other cities
- Columbus, OH5 studies
- Boston, MA5 studies
- Houston, TX5 studies
- New York City, NY4 studies
- Denver, CO4 studies
- Nashville, TN4 studies
- Washington, DC4 studies
- Durham, NC4 studies
- Rochester, NY4 studies
- Wichita, KS3 studies
- Sacramento, CA3 studies
- Cincinnati, OH3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Prostate Cancer45 studies
- Breast Cancer44 studies
- Lung Cancer41 studies
- Cancer (all types)36 studies
- Colorectal Cancer30 studies
- Pancreatic Cancer30 studies
- Metastatic Cancer26 studies
- Obesity24 studies
- Bladder Cancer24 studies
- Ovarian Cancer23 studies
- Heart Failure23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.